Cargando…

Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS

BACKGROUND: In this paper we describe a novel method to achieve high yield bacterial expression of a small protein domain with considerable therapeutic potential; Domain I of Beta-2-glycoprotein I (β2GPI). β2GPI is intrinsic to the pathological progression of the Antiphospholipid Syndrome (APS). Pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonnell, Thomas, Pericleous, Charis, Laurine, Emmanuelle, Tommasi, Rita, Garza-Garcia, Acely, Giles, Ian, Ioannou, Yiannis, Rahman, Anisur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Methodology Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650279/ https://www.ncbi.nlm.nih.gov/pubmed/26576675 http://dx.doi.org/10.1186/s12896-015-0222-0

Ejemplares similares

Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies
por: Pericleous, Charis, et al.
Publicado: (2011)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
por: McDonnell, Thomas, et al.
Publicado: (2020)

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
por: McDonnell, Thomas, et al.
Publicado: (2018)

Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
por: Cousins, Laura, et al.
Publicado: (2015)

A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli
por: Ioannou, Yiannis, et al.
Publicado: (2006)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
por: Willis, Rohan, et al.
Publicado: (2022)

Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β(2)-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis
por: Pericleous, Charis, et al.
Publicado: (2015)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
por: McDonnell, Thomas C. R., et al.
Publicado: (2018)

Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK
por: Bourke, Lauren T, et al.
Publicado: (2017)

Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
por: Artim-Esen, Bahar, et al.
Publicado: (2017)

PEGylated drugs in rheumatology—why develop them and do they work?
por: McDonnell, Thomas, et al.
Publicado: (2014)

Novel Assays of Thrombogenic Pathogenicity in the Antiphospholipid Syndrome Based on the Detection of Molecular Oxidative Modification of the Major Autoantigen β(2)-Glycoprotein I
por: Ioannou, Yiannis, et al.
Publicado: (2011)

Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study
por: Croca, Sara, et al.
Publicado: (2014)

Purified IgG from Patients with Obstetric but not IgG from Non-obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion
por: Poulton, Katie, et al.
Publicado: (2015)

Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
por: Artim-Esen, Bahar, et al.
Publicado: (2015)

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
por: Pericleous, Charis, et al.
Publicado: (2020)

Methodology of generation and purification of anti-beta 2 glycoprotein I antibodies
por: Alarcon, Marcelo, et al.
Publicado: (2019)

Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies
por: Bergmann-Leitner, Elke S, et al.
Publicado: (2008)

Specific domain V reduction of beta-2-glycoprotein I induces protein flexibility and alters pathogenic antibody binding
por: Buchholz, Ina, et al.
Publicado: (2021)

Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation
por: Albay, A, et al.
Publicado: (2019)

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
por: Farina, Nicola, et al.
Publicado: (2022)

Comparison of Methods for the Purification of Alpha-1 Acid Glycoprotein from Human Plasma
por: McCurdy, Teresa R., et al.
Publicado: (2011)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage
por: McDonnell, Thomas, et al.
Publicado: (2022)

Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis
por: Lambrianides, Anastasia, et al.
Publicado: (2011)

A model linking clinical workforce skill mix planning to health and health care dynamics
por: Masnick, Keith, et al.
Publicado: (2010)

The purification of reduced β2-glycoprotein I showed its native activity in vitro
por: Zhou, Saijun, et al.
Publicado: (2017)

A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations
por: Jiang, Debbie, et al.
Publicado: (2021)

Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
por: de Laat, Bas, et al.
Publicado: (2010)

Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19
por: Garcia-Arellano, Gisela, et al.
Publicado: (2023)

STUDIES ON THE PURIFICATION OF POLIOMYELITIS VIRUS : I. YIELDS AND ACTIVITY OF PREPARATIONS OBTAINED BY DIFFERENTIAL CENTRIFUGATION
por: Loring, Hubert S., et al.
Publicado: (1942)

THE PURIFICATION OF HYPERTENSIN I
por: Skeggs, Leonard T., et al.
Publicado: (1954)

Improved methods for magnetic purification of malaria parasites and haemozoin
por: Kim, Charles C, et al.
Publicado: (2010)

Pancreatic Beta-Cell Purification by Altering FAD and NAD(P)H Metabolism
por: Smelt, M. J., et al.
Publicado: (2008)

Type I Error Control for Tree Classification
por: Jung, Sin-Ho, et al.
Publicado: (2014)

The effect of column purification on cDNA indirect labelling for microarrays
por: Molas, M Lia, et al.
Publicado: (2007)

Auxin Extraction and Purification Based on Recombinant Aux/IAA Proteins
por: Su, Yi, et al.
Publicado: (2017)

Isolation, purification, and full NMR assignments of cyclopamine from Veratrum californicum
por: Oatis, John E, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_qaor2e6m1sudfaja5q5cm7ann4